ACE inhibitors also in stable coronary heart disease?;Koronare herzkrankheit: ACE-Hemmer auch bei stabiler KHK?

Deutsche Apotheker Zeitung

Volumn 144, Issue 9, 2004, Pages 42-44

  Jungmayr, Petra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

CARDIOVASCULAR RISK; DRUG EFFICACY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT COMPLIANCE; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT OUTCOME;

EID: 1542350016     PISSN: 00119857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. The european trial on reduction of cardiac events with Perindopril in stable coronary artery disease investigators: Efficacy of perinopril in reduction of cardiovascular events among patients with stable coronary disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362, 782-788 (2003).
2. H. White: Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors? Lancet 362, 755-756 (2003).